Format

Send to

Choose Destination
Viruses. 2016 Sep 20;8(9). pii: E261.

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection.

Author information

1
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 rue Koeberlé, 67000 Strasbourg, France. e.verrier@unistra.fr.
2
Université de Strasbourg, 4 rue Blaise Pascal, 67081 Strasbourg, France. e.verrier@unistra.fr.
3
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 rue Koeberlé, 67000 Strasbourg, France. colpitts@unistra.fr.
4
Université de Strasbourg, 4 rue Blaise Pascal, 67081 Strasbourg, France. colpitts@unistra.fr.
5
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 rue Koeberlé, 67000 Strasbourg, France. catherine.schuster@unistra.fr.
6
Université de Strasbourg, 4 rue Blaise Pascal, 67081 Strasbourg, France. catherine.schuster@unistra.fr.
7
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 rue Koeberlé, 67000 Strasbourg, France. mirjam.zeisel@unistra.fr.
8
Université de Strasbourg, 4 rue Blaise Pascal, 67081 Strasbourg, France. mirjam.zeisel@unistra.fr.
9
Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3 rue Koeberlé, 67000 Strasbourg, France. thomas.baumert@unistra.fr.
10
Université de Strasbourg, 4 rue Blaise Pascal, 67081 Strasbourg, France. thomas.baumert@unistra.fr.
11
Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, 1 place de l'hôpital, 67000 Strasbourg, France. thomas.baumert@unistra.fr.

Abstract

Chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) infections are major causes of liver disease and hepatocellular carcinoma worldwide. Despite the presence of an efficient preventive vaccine, more than 250 million patients are chronically infected with HBV. Current antivirals effectively control but only rarely cure chronic infection. While the molecular biology of the two viruses has been characterized in great detail, the absence of robust cell culture models for HBV and/or HDV infection has limited the investigation of virus-host interactions. Native hepatoma cell lines do not allow viral infection, and the culture of primary hepatocytes, the natural host cell for the viruses, implies a series of constraints restricting the possibilities of analyzing virus-host interactions. Recently, the discovery of the sodium taurocholate co-transporting polypeptide (NTCP) as a key HBV/HDV cell entry factor has opened the door to a new era of investigation, as NTCP-overexpressing hepatoma cells acquire susceptibility to HBV and HDV infections. In this review, we summarize the major cell culture models for HBV and HDV infection, discuss their advantages and limitations and highlight perspectives for future developments.

KEYWORDS:

NTCP; Viral cell entry; hepatocytes; hepatoma cells; life cycle

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center